An expression of the estrogen receptor is a major indicator for potential responses with the hormonal treatment, tamoxifen (TAM). Previous statistics have shown that approximately 70% breast cancer (BC) patients diagnosed in Indonesia will be endocrine-receptor positive, insinuating a positive outlook for successful treatment with the drug. Moreover, TAM has since been proven to circumvent BC recurrence, primarily in pre-menopausal woman and reports have shown 170,000 prescriptions filled in 2015.
Read more here:
